after 12pm ships next business day Same or Next Day Dispatch Order before 12pm GMT for same-day dispatch
40 High homocysteine is associated with poor response, and high B12 levels with a good response to anti-depressant treatment
CJC-1295 No DAC, also referred to as Modified GRF 1-29, is a modified analogue of growth hormone-releasing hormone used in research models examining short-acting GHRH receptor pathway activity
Distributed under the brand names Geref and Geref Diagnostic, it gained FDA approval in 1997 as a treatment for growth hormone deficiency but was discontinued in 2008 not out of concern for safety or lack of efficacy, but because of manufacturing difficulties.2 3 Yet it remains available in compounded form with a prescription from a licensed healthcare provider
Our team is happy to answer questions, explain the process, and help you decide if B12 therapy is right for you
It is highly desirable to integrate different therapeutic methods together to achieve multimodal synergistic therapy for cancer treatment